Cargando…

Biomarkers Associated With Tumor Ki67 and Cathepsin L Gene Expression in Prostate Cancer Patients Participating in a Presurgical Weight Loss Trial

Our previous presurgical weight loss trial among 40 prostate cancer patients found that rapid (but not slow) weight loss resulted in increased tumor Ki67 and Cathepsin L (CTSL) gene expression. In follow-up analyses, we strove to better understand these unexpected findings. A correlative study was u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frugé, Andrew D., Smith, Kristen S., Bail, Jennifer R., Rais-Bahrami, Soroush, Demark-Wahnefried, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527501/ https://www.ncbi.nlm.nih.gov/pubmed/33042834 http://dx.doi.org/10.3389/fonc.2020.544201

Ejemplares similares

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2017)

Physiological Effort in Submaximal Fitness Tests Predicts Weight Loss in Overweight and Obese Men with Prostate Cancer in a Weight Loss Trial
por: Frugé, Andrew D, et al.
Publicado: (2017)

Characteristics of cancer patients participating in presurgical lifestyle intervention trials exploring effects on tumor biology
por: Dasher, John A., et al.
Publicado: (2017)

Exploring effects of presurgical weight loss among women with stage 0–II breast cancer: protocol for a randomised controlled feasibility trial
por: Tsuruta, Yuko, et al.
Publicado: (2016)

Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2016)

Erratum to: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2017)

Reply to “Phase II prospective randomized trial of weight loss prior to radical prostatectomy”
por: Demark-Wahnefried, W., et al.
Publicado: (2018)

Comment on “The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial”
por: Bail, Jennifer R., et al.
Publicado: (2020)

Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2008)

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
por: Mesko, Shane, et al.
Publicado: (2013)

Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics
por: Demark‐Wahnefried, Wendy, et al.
Publicado: (2019)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Personalized prostate cancer care
por: Rais-Bahrami, Soroush, et al.
Publicado: (2018)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
por: Huang, Liang, et al.
Publicado: (2013)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis
por: IFERE, GODWIN O., et al.
Publicado: ( 201)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
por: Azizan, Nornazirah, et al.
Publicado: (2018)

Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy
por: He, Jun, et al.
Publicado: (2023)

Can we use Ki67 expression to predict prostate cancer aggressiveness?
por: MAIA, RONALDO, et al.
Publicado: (2022)

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
por: Hammarsten, Peter, et al.
Publicado: (2019)

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer
por: Glaser, Zachary A., et al.
Publicado: (2018)

Role of molecular imaging in the detection of localized prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Primary Outcomes of a Randomized Controlled Crossover Trial to Explore the Effects of a High Chlorophyll Dietary Intervention to Reduce Colon Cancer Risk in Adults: The Meat and Three Greens (M3G) Feasibility Trial
por: Frugé, Andrew D., et al.
Publicado: (2019)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2017)

Assessment of Expression of Ki-67 in Benign and Malignant Prostatic Lesions among Sudanese Patients
por: Mohamed, Albasheer Abdelmalik, et al.
Publicado: (2018)

Deep learning–based radiomic nomograms for predicting Ki67 expression in prostate cancer
por: Deng, Shuitang, et al.
Publicado: (2023)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Integration of magnetic resonance imaging into prostate cancer nomograms
por: Brinkley, Garrett J., et al.
Publicado: (2022)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and Progression
por: Azrad, Maria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m0i7o9f9gkpjmtgm3ag62a4npr